Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Textual)

v3.4.0.3
Commitments and Contingencies (Details Textual)
1 Months Ended 3 Months Ended
Jul. 09, 2015
USD ($)
Jan. 31, 2012
Mar. 31, 2016
USD ($)
ft²
Commitments and Contingencies [Line Items]      
License Expiration Period   12 years  
License Costs     $ 12,500
Licensor [Member]      
Commitments and Contingencies [Line Items]      
Area of Land | ft²     4,516
Valeant Pharmaceuticals International Inc [Member] | Licensing Agreements [Member]      
Commitments and Contingencies [Line Items]      
Payments to Acquire Intangible Assets $ 1,000,000    
Proceeds from Sale of Intangible Assets $ 32,500,000